Last update 19 Jul 2024

Ranibizumab biosimilar(Qilu Pharma)

Overview

Basic Info

Drug Type
Fab fragment, Biosimilar
Synonyms
Ranibizumab biosimilar, 重组抗VEGF人源化单克隆抗体Fab(齐鲁制药), BCD 300
+ [4]
Target
Mechanism
VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors)
Inactive Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view First Approval Timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Choroidal Neovascularization
EU
15 Jan 2024
Choroidal Neovascularization
IS
15 Jan 2024
Choroidal Neovascularization
LI
15 Jan 2024
Choroidal Neovascularization
NO
15 Jan 2024
Diabetic macular oedema
EU
15 Jan 2024
Diabetic macular oedema
IS
15 Jan 2024
Diabetic macular oedema
LI
15 Jan 2024
Diabetic macular oedema
NO
15 Jan 2024
Proliferative retinopathy with diabetes mellitus
EU
15 Jan 2024
Proliferative retinopathy with diabetes mellitus
IS
15 Jan 2024
Proliferative retinopathy with diabetes mellitus
LI
15 Jan 2024
Proliferative retinopathy with diabetes mellitus
NO
15 Jan 2024
Wet age-related macular degeneration
EU
15 Jan 2024
Wet age-related macular degeneration
IS
15 Jan 2024
Wet age-related macular degeneration
LI
15 Jan 2024
Wet age-related macular degeneration
NO
15 Jan 2024
Retinal vein occlusion-related macular edema
EU
15 Dec 2023
Retinal vein occlusion-related macular edema
IS
15 Dec 2023
Retinal vein occlusion-related macular edema
LI
15 Dec 2023
Retinal vein occlusion-related macular edema
NO
15 Dec 2023
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dystrophy, MacularNDA/BLA
CN
29 Jan 2023
Wet Macular DegenerationPhase 1
CN
20 Dec 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free